Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV)

Objective We aimed to compare the safety and efficacy of a doxycycline-based regimen against Cameroon National Standard Guidelines (hydroxychloroquine plus azithromycin) for the treatment of mild symptomatic COVID-19. Methods We conducted an open-label, randomized, non-inferiority trial in Cameroon...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobngwi, Eugene, Zemsi, Sylvain, Guewo, Magellan, Katte, Jean-Claude, Kouanfack, Charles, Mfeukeu, Liliane, Zemsi, Armel, Wasnyo, Yves, Ntsama Assiga, Antoinette, Ndi Manga, Arnaud, Sobngwi-Tambekou, Joelle, Ngatchou, William, Moussi Omgba, Charlotte, Mbanya, Jean-Claude, Ongolo Zogo, Pierre, Fouda, Pierre Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588815/
https://www.ncbi.nlm.nih.gov/pubmed/37868535
http://dx.doi.org/10.7759/cureus.45619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588815/
https://www.ncbi.nlm.nih.gov/pubmed/37868535
http://dx.doi.org/10.7759/cureus.45619

Ejemplares similares